Cytokine Estimation in Chronic Viral Hepatitis with Autoimmune Impairments by Ismailova, A. (Adolat) & Nabieva, U. (Umida)
International Journal of Public Health Science (IJPHS) 
Vol.2, No.2, June 2013, pp. 39~42 
ISSN: 2252-8806      39 
  
Journal homepage: http://iaesjournal.com/online/index.php/IJPHS 
Cytokine Estimation in Chronic Viral Hepatitis with 
Autoimmune Impairments 
 
Umida Nabieva, Adolat Ismailova 
Immunocytokine DPT, Institute of Immunology, Academy of Science, Uzbekistan 
 
 
Article Info  ABSTRACT 
Article history: 
Received  Jan 6, 2013 
Revised  Feb 15, 2013 
Accepted May 16, 2013 
 
 
The pattern of autoimmune impairments was studied in patients with chronic 
viral hepatitis in association with the level of inflammatory cytokines and 
interferon status. Study was conducted in groups of patients with various 
levels of the detected autoantibodies to ssDNA. Autoantibodies to ssDNA 
were found in 37.7% of patients with HCV. In the group of HCV patients 
with autoimmune disorders, the levels of the cytokines and interferon levels 
were considerably higher than those in the group of patients without 
associated autoimmune diseases. Keyword: 
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1. INTRODUCTION  
Despite significant increase in knowledge of etiology and immunopathogenesis of the chronic 
diseases of liver for the last decade [2];[6], many questions related to mechanisms for the development and 
progression of the pathological process remain unclear. Until very recently, the mechanisms of the immune 
response were studied on some populations of cells of the immune system; in the same time deeper 
mechanisms as cytokine were not studied at all. It is well known that cytokines play an important role in the 
immune response; they take an active part in the developing of inflammatory process and destroying of liver, 
particularly in viral hepatitis B and C [2];[4];[8];[18]. There are contradictory data regarding role of the 
regulatory cytokines interleukin 10 (IL-10), interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α) in the 
course and outcome of hepatitis C and their connection with the development autoimmune disorders. In the 
same it is known that regulatory cytokines (IL-10, IL-6, TNF-α) make significant contribution to the 
developing of chronic hepatitis [5];[7];[18]. The interferon’s system that participates in antiviral and anti-
neoplastic protection has an essential value in the development of the chronic hepatitis C and possesses anti-
proliferation, immunomoduling and radio protective qualities [3];[9];[10].  
Full value of response of an organism to a viral infection depends on sufficient production of 
interferons. They  protect an organism from  invading viruses, limit distribution of a virus from the infected 
cages, reduce the period of viremia, reduce the severity of a current infectious process, protect from bacteria, 
the elementary, activate lymphocytes, suppress growth of malignancies, basically, they are an important 
mediators of immune system. The current state and the disease outcome depend on them. Delayed or lowered 
production of endogen interferon can lead to chronization of process up to a lethal outcome [11]-[13].  
It is known, that at long persistency of hepatitis C viruses there is a possibility of development of 
autoimmune reactions directed against the own tissues of an organism. [1], and it aggravates current state of 
chronic hepatitis [16];[17]. 
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Active process of disease course leads to development of auto-aggeression, expressed in the 
releasing of high titers of antibodies. It can promote occurrence of inflammatory reactions and harm body 
tissues. Detecting of G class autoimmune antibodies of to one-chained DNA (ssDNA) is typical to assess an 
auto-immunization in patients with chronic viral hepatitis. Autoantibodies to denatured (single stranded) 
DNA (ssDNA) are not specific to certain diseases and they are main parts of the majority of nuclear 
antibodies [14]. Produced autoantibodies lead to pro-and anti-inflammatory cytokins disballance, playing 
very important role in the developing of the immune response of an organism. Therefore the detection of one-
chained DNA and detection and assessment of the spectrum of pro-and anti-inflammatory cytokins play an 
important role in diagnostics, and also in treatment tactics of patients with chronic viral hepatitis. 
 
 
2. RESEARCH METHOD  
We examined blood serum of 220 patients for HBsAg and anti HCV IgG. Duration of illness in 
examined patients was from 2 to 10 years. The diagnosis of the chronic hepatitis B and C was made based on 
the combination of collected clinical, epidemiological, laboratory and instrumental data according to the 
Regulatory Order of the Ministry of Health of Uzbekistan. Patients were divided into two groups and 
according to the appearance of the auto-antibodies to ssDNA (the first group with positive autoantibodies to 
ssDNA, the second group – negative). Additionally, for confirmation of morphological lesions and chronic 
process the ultrasound of liver was conducted that revealed diffuse parenchyma changes and 
hepatosplenomegaly. Levels of ssDNA, IL–10, IL-6, TNF-α, IFN-α, IFN-γ  in peripheral blood were detected 
by sandwich ELISA (solid-phase enzyme immunoassay (EIA) with using peroxidase as a indicator enzyme 
(reagents sets “Vector Best” Novosibirsk, the Russian Federation).  
 
 
3. RESULTS AND ANALYSIS  
The analysis of the collected data of the detected autoimmune disorders markers has shown: that in 
average 37.8% of the examined patients with chronic hepatitis C have autoantibodies to ssDNA.  
It is known, that the interferon system is an integrated part of the immune system which provides 
coordination of proliferation, differentiation and activation of effector immune cells. An evaluation of a 
functional condition of system of interferons is the interfron status that includes a detection of IFN - α. IFN - 
γ which are powerful stimulators and inductors of the non-specific immune response. 
IFN - α has a direct anti-viral and mediated immunomoduling activity, that play one of the basic 
roles in elimination of hepatitis C. IFN - α is produced by practically all cells of an organism, but in the 
greatest measure by macrophages and lymphocytes. IFN - α is a powerful antiviral protein, it and has served 
as a reason for detecting of IFN - α at patients with chronic viral hepatitis. 
The analysis of the collected data has shown, that in groups of patients compared not depending to 
revealing of antibodies to ssDNA, the level IFN - α has been considerably suppressed. In group of patients 
with positive result for autoantibodies to ssDNA interferon, the-alpha level has been suppressed in 1, 9 times 
comparing to a control group (р <0,001), and in group of patients with negative result of revealing 
autoantibodies to ssDNA – in 2, 6 times (р <0,001) (fig. 1). 
IFN - γ is one of cytokines produced by Th-1 – type and possesses antiviral and against tumor 
qualities; activates mediated monocytes and macropages, natural killers (cytotoxicity), proliferation and 
differentiation of T-lymphocytes: stimulates maturing of marrow cells – predecessors of monocytes; 
suppresses the growth of tumors, reproduction of viruses in cells, proliferation, production and secretion of 
cytokins by Th-2 lymphocytes (IL-4, IL-10, etc.), proliferation of  B cells and synthesis of immunoglobulin 
Е, proliferation of  somatic cells, secretion of immunoglobulin G, strengthens a differentiation of tumor cells, 
antiviral, anti-microbial, anti-parasitic resistance and tumorocid activity of TNF - α, and as well 
противовирусную activity. In this connection detection of IFN - γ in blood is rather important. 
 
 
IJPHS 
 
Cytokine estimation in chronic viral hepatitis with autoimmune impairements (Umida Nabieva)
Figure 1. Interferons and core cytokins of 
connection with detection of antibodies to ssDNA
 
It was detected by the conducted research that the levels of IFN 
with positive oDNA  was not significantly (in 1, 2 times) raised and authentically did not differ from 
indicators of control group (> 0,05), and in group of
concentration in blood was marked almost in 2 times in comparison with group of healthy people  (
The following stage of our research has been devoted to studying of spectrum pro
inflammatory cytokins IL-6, IL-10 and TNF
extremely pleiotropic and activate tissues around them. They trigger wide range of biological activity by 
lymphoid and non lymphoid cells. It is detected that I
inflammation, regulate immune and acute phase response, inflammation, onco
TNF–α also plays a role in the destroying of liver, exacerbate development of fibrosis and portal 
inflammation in hepatitis C patients. One of the major functions of IL
of the antibody producing cells from B cells, as well as a production of immunoglobulins. IL
activation of T lymphocytes, induces synthesis of 
reactive protein. 
Studying of the spontaneous production of IL
between data in the both groups of patients with chronic hepatitis C and control group (p<0,05
with chronic hepatitis C have higher levels of these cytokines in comparison with control group, but if in the 
group of patients without autoantibodies they have been higher in 1.57 for TNF
in groups of patients with autoantibodies they were higher in 2.31 and in 2.18 times respectively (p<0,05).
Cytokine IL–10 that is produced by Th
important in the pathogenesis of hepatic lesions. The main mechanisms o
immunomodulatory, immunosuppressive. 
cells and stimulates the secretion of immunoglobulins.  Additionally, the level of IL
assess the activity of regulatory T4 cells (T
cytokine IL–10 [15]. 
Analysis of the collected data revealed that there is a tendency of the decrease of IL
chronic patients. It was shown, that patients with
3.2 fold (p<0.05) and patients without antibodies have levels of IL
 
 
4. CONCLUSION  
Patients with positive autoimmune markers have the disballance of interfer
suppressed production of IFN - γ, and activated production of IFN 
cytokines by Th-1 and Th-2 cells, shown by suppression of production IL
IL-6. 
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